Background Osteoporosis is an abnormal reduction in bone mass and bone deterioration
leading to increased fracture risk. Alendronate belongs to the bisphosphonate class of …

Purpose To summarize available evidence comparing the transdermal and the oral
administration routes of hormone replacement therapy (HRT) in postmenopausal women …

Due to its minimal systematic adverse effects, transdermal estrogen is widely used for the
prevention of osteoporosis in postmenopausal women. The present meta-analysis aimed to …

Osteoporosis is one of the most common metabolic bone disease among pre-and
postmenopausal women. As the precursors of osteoclast cells, circulating monocytes play …

Остеопороз–заболевание скелета, при котором снижена прочность кости и повышен
риск переломов. Прочность кости отражает интеграцию двух главных характеристик …

Остеопороз (ОП)–наиболее распространенное заболевание скелета,
сопровождающееся прогрессивным снижением прочности кости, повышением ее …

Combination therapy includes the concomitant or sequential use of compounds sharing the
same mode of action (eg, two or more inhibitors of bone resorption) or with distinct pathways …

В обзорной статье подчеркнуто, что первым методом профилактики остеопороза (ОП)
у молодых женщин с эстрогенным дефицитом остается гормональная терапия. При …

Major advancements in the treatment of osteoporosis have occurred over the last decade.
Therapies including the anti-resorptive drugs such as alendronate and risedronate have …

Although osteoporosis is common among the female elderly, in young adults who are
associated with breast cancer treatment or under ovarian abrasion are also at risk to low …